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1. Introduction 
Chronic kidney disease is an increasing public health problem. In the United States, the 
prevalence is estimated to be approximately 11% of the adult population. Chronic kidney 
disease may progress to end-stage renal failure, a condition associated with high morbidity 
and mortality. Diabetes mellitus (DM) is one of the main causes of kidney disease and end-
stage renal failure. In the United States, DM is the primary diagnosis in 44% of all new cases 
of renal replacement therapy. Vascular complications are the most common cause of diabetic 
nephropathy, but it is possible that urinary tract infections (UTIs) also contribute to renal 
insufficiency in patients with DM.  
The urinary tract is normally sterile. However, asymptomatic bacteriuria (ASB), which is 
defined as the presence of a positive urine culture with at least 10e5 cfu/ml collected from a 
patient without symptoms of a UTI, is a common phenomenon, especially in women. 
Different studies report a prevalence of approximately 1-5% among healthy young women, 
increasing to over 20% in the elderly and 12-26% in women with DM. A Swedish study 
among 1,462 adult women showed that women with bacteriuria at study entry had an 
increased risk of having bacteriuria six and twelve years later, compared to women without 
bacteriuria (Odds Ratio (OR) 6.9 and 3.1, after six and twelve years, respectively). Another 
Swedish study among 116 schoolgirls with ASB showed that at baseline renal parenchymal 
reduction was found in 10.3%, while reflux was found in 20.7%, but only 30% of the 116 
patients had a history referable to an earlier UTI. A 3-year follow-up of these 116 schoolgirls 
with ASB (treated or untreated) showed that the risk of developing renal damage as a result 
of ASB in a schoolgirl with a roentgenographically normal urinary tract seemed to be small. 
Escherichia coli is the most prevalent causative microorganism in both symptomatic and 
asymptomatic bacteriuria, accounting for more than 80% of uncomplicated UTIs. Previous 
studies have demonstrated that patients with renal scarring due to pyelonephritis are at 
increased risk for the development of hypertension and chronic kidney disease. Results from 
previous in vitro and in vivo studies indicate that a UTI with E. coli can lead to renal damage, 
either by the microorganism itself or by the following host response. For instance, it has been 
shown that type 1 fimbriae (the adhesive organelles at the outer surface of the bacterial  
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membrane) can cause scarring in the renal parenchyma of rats, with large foci of inflammation. 
This might be due to the activation of polymorphonuclear leukocytes by type 1 fimbriated-
strains, which leads to the release of tissue destroying enzymes. Mice models have shown that 
although neutrophils are important in bacterial clearance, they can also cause renal damage.  
In a clinical study, renal scarring was detected in 29 of 63 adult women ten to twenty years 
after hospitalization for pyelonephritis. In contrast, no study has convincingly shown that 
ASB can lead to a clinically relevant decline in renal function in otherwise healthy women. 
Several authors in the first half of the twentieth century have suggested a role of bacteriuria 
in the etiology of hypertension, but the pathogenesis is not understood. 
2. ASB and renal function decline in healthy women 
2.1 Study population, baseline cohort 
Between 1974 and 1986 all women, born between 1911 and 1945, who lived in the city of 
Utrecht and surroundings, the Netherlands, were invited for a breast-cancer-screening 
program, with a participation rate of 68 to 72%. A total number of 38,994 women, aged 39 to 
68 years old at intake, participated (the baseline cohort). Baseline measurements, performed 
between 1974 and 1986, included extensive questionnaires, a short medical examination, and 
the collection of a midstream morning urine sample. Data obtained through the 
questionnaires included age, marital status, smoking habits, parity, menopausal age, diet 
and drug use. During the medical examination weight and height were measured. 
Approximately 200 ml urine was stored in plastic polypropylene jars, without preserving 
agents, and stored at –20°C for future analyses. All women gave oral consent to use their 
data and urine samples for future scientific research.  
2.2 Study population, follow-up cohort  
From 1993 to 1997, 50,313 women living in Utrecht and surroundings who were scheduled for 
breast cancer screening during this period received an invitation by mail to join an additional 
study to assess the relation between nutrition and cancer and other chronic diseases, the 
Prospect-EPIC study (the follow-up cohort). A total of 17,357 women (participation rate 34.5%) 
agreed to take part . Participants were between 49 and 70 years old at enrolment. Information 
was collected on the basis of two self-administered questionnaires and a medical examination 
including blood pressure. Non-fasting blood samples were successfully drawn from 97.5% of 
the women, and stored under liquid nitrogen at –196°C. Approximately 88% of the women 
signed a detailed informed consent, enabling the researchers to use their blood samples for 
future analysis, and to obtain information on future morbidity and mortality.  
To address the relation between E. coli bacteriuria and renal function development, we 
performed a full cohort analysis for women who participated in both the baseline cohort 
and the follow-up cohort. E. coli bacteriuria was diagnosed by a real-time Polymerase Chain 
Reaction in this urine sample. Participants were between 49 and 70 years old at enrolment. 
The mean duration of follow-up was 11.5 ± 1.7 years, ranging from 8.1 to 18.6 years from 
baseline until participation in the follow-up study. Forty-eight of 490 women (10%) were 
classified with E. coli bacteriuria at baseline. At study endpoint, the mean creatinine 
clearance for women with baseline bacteriuria was 87 ± 21 ml and without baseline 
bacteriuria 85 ± 18 ml per minute, respectively (Figure 1). E. coli bacteriuria at baseline was 
not associated with creatinine levels at follow-up, adjusted for age and weight and the 
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distribution in stages of renal function was not different for women with bacteriuria 
compared to women without bacteriuria. 
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Fig. 1. Differences in creatinine clearance between women WITHOUT DM with and without 
ASB. (Meiland R, Stolk RP, Geerlings SE, Peeters PH, Grobbee DE, Coenjaerts FE, Brouwer 
EC, Hoepelman AI. Association between Escherichia coli bacteriuria and renal function in 
women: long-term follow-up. Arch Intern Med. 2007 Feb 12;167(3):253-7.) 
2.3 Nested case-control study population 
To obtain follow-up information on end-stage renal failure, we obtained data from the Renal 
Replacement Registry Netherlands (RENINE) that were available May 2002. RENINE is a 
foundation in which all Dutch nephrologists participate and where patients are registered 
who at one time have used kidney replacing therapy (hemodialysis or renal 
transplantation), with a coverage rate throughout the years of nearly 100%. Data from the 
baseline cohort and RENINE were matched on (maiden and married) name combined with 
date of birth to select the cases. A group consisting of four times the number of cases was 
randomly selected from the baseline cohort to form the control group. Four women 
participated in the follow-up cohort and were also selected as one of the cases who received 
kidney replacing therapy during follow-up; one woman underwent kidney transplantation 
before blood withdrawal (and was excluded for the cohort analysis), three women 
developed end-stage renal failure thereafter (and were included in both analyses). After 
excluding four individuals with a missing urine sample 49 cases and 206 controls were 
included. Among the cases, the mean duration until the date of kidney replacing therapy 
was 13.8 ± 7.4 years, with a minimum and maximum duration of 1.6 and 25.5 years, 
respectively. In the control group, the mean follow-up (i.e. the time from participation in the 
baseline cohort until study-endpoint in May 2002) was 27.0 ± 0.2 years. 
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No difference in duration until kidney replacing therapy was found between bacteriuric and 
non-bacteriuric individuals (14.6 versus 13.7 years, p = 0.80). Seven of 49 women who 
developed renal failure had E. coli bacteriuria at baseline, compared to 29 of 206 women in 
the control group (both 14%). The OR for the development of renal failure in the presence of 
E. coli bacteriuria, corrected for age, was 1.1 (95% CI 0.4–2.8, p = 0.86). 
In a Swedish study the prevalence of ASB in women was 4%. After 15 years a 
reinvestigation was carried out, 40 cases (with ASB) and 40 age-matched healthy controls 
participated. Nobody had developed progressive renal disease. The age-dependent decrease 
after 15 years was the same in both groups.  
The results of these longitudinal findings give strong support to the absence of an 
association between ASB and renal function decline in healthy women. As an explanation, 
Svanborg et al. found that certain E. coli strains stop expressing adherence factors like type 1 
and P fimbriae once they have established bacteriuria. Therefore, these strains can remain 
present in the bladder without triggering an inflammatory response from the host and 
without side effects.  
In conclusion, no relation between ASB and renal function decline has been demonstrated in 
healthy women. It has been recommended in American and European guidelines not to 
screen or to treat ASB in premenopausal non-pregnant women and older persons living in 
the community. The results of these studies confirm these recommendations.  
3. ASB and hypertension in healthy women 
Several authors in the first half of the twentieth century have suggested a role of bacteriuria 
in the etiology of hypertension. For instance, Kass showed small differences in blood 
pressure between bacteriuric and non-bacteriuric women aged 15 to 64 years old.  
The association between ASB and hypertension was investigated in a cohort study of 444 
women who were followed for the development of hypertension in relation to E. coli 
bacteriuria at baseline. Hypertension was defined as the (previous) use of antihypertensive 
medication and/or a measured systolic blood pressure of at least 160 mm Hg or a diastolic 
blood pressure of 95 mm Hg or higher. A history of having had a heart attack or stroke was 
assessed at follow-up by the two additional questions: “Have you ever had a heart attack / 
stroke?”. Mean age at baseline was 45.0 ± 3.2 years and 48 women (10%) had E. coli bacteriuria. 
After 11.5 years women who had E. coli bacteriuria at baseline had a mean blood pressure at 
study endpoint of 133 ± 20 mmHg systolic and 78 ± 11 mmHg diastolic, and women without 
bacteriuria had values of 129 ± 20 and 78  ± 11 mmHg, respectively (p-value for difference 0.33 
and 0.88). Interestingly, although E. coli bacteriuria was not associated with the blood pressure 
as a continuous variable, it was associated with the development of hypertension during 
follow-up (OR 2.8, 95% CI 1.4–5.5). This was mainly due to more bacteriuric women that 
started antihypertensive drugs when compared to non-bacteriuric participants. This 
association remained statistically significant after correction for age, weight and creatinine. 
Eight of the 45 women (18%) who had to be excluded because of the use of antihypertensive 
medication at baseline, had E. coli bacteriuria, which was higher than the percentage of 9% of 
the final study group without antihypertensive drugs at baseline (p = 0.06). However, no 
association between ASB and renal function decline was demonstrated. The incidence of heart 
attacks or strokes was not increased among women with bacteriuria at baseline. These results 
suggest that bacteriuria increase also the chance to develop hypertension.  
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Although more recent studies also found a correlation, only one prospective study has shown 
that bacteriuria is associated with the development of hypertension. In the above mentioned 
cohort study, a higher prevalence of hypertension in the bacteriuric group after 12 years of 
follow-up was found. However, the underlying mechanism of this finding is not clear. 
Hypertension is a lasting increase in blood pressure with a heterogeneous etiology consisting 
of both genetic and environmental factors. Patients share the inability to excrete sodium at a 
normal arterial pressure. If bacteriuria would lead to hypertension, the most attractive 
explanation would be that hypertension arises secondary to renal scarring caused by the (type 
1 fimbriae of the) uropathogens. In the multivariate analysis, correction for creatinine did not 
change the results, but hypertension can occur before the reduction in creatinine clearance 
becomes apparent. An alternative explanation is that both bacteriuria and hypertension are 
found more frequently among individuals with comorbidity or that they share a same 
(currently unknown) cause. This is supported by the higher prevalence of bacteriuria among 
women who used antihypertensive drugs at baseline. Given the importance of hypertension 
the nature of this correlation needs to be studied in future studies. 
4. ASB and renal function decline and hypertension in patients with DM 
Women with DM have an increased prevalence of ASB, but also an increased risk on 
symptomatic UTI’s and developing complications of UTI’s such as renal abscesses. It was 
also shown that at short term follow-up treatment of ASB in women with DM did not 
appear to reduce complications. E. coli is the leading uropathogen in non-diabetic as well as 
in diabetic patients. Ninety percent of E. coli possesses type 1 fimbriae, the adhesive 
organelles found at the outer bacterial membrane. We have shown in vitro that type 1-
fimbriated E. coli have an increased adherence to uroepithelial cells voided by women with 
DM. Others demonstrated that UTI’s with type 1-fimbriated E. coli can lead to scar 
formation in the renal parenchyma of infected rats.At present, conclusive and prospective 
data with a long follow-up period directly relating ASB (with E. coli) to long-term risk of 
renal failure in diabetic patients are lacking.  Taken together, we hypothesized that ASB in 
women with DM could lead to a faster decline in renal function, and decided to enlarge our 
cohort of diabetic women and to prolong the follow-up period. Besides the effects on renal 
function, we also studied the influence of ASB on the development of hypertension.  
The association between ASB and renal function decline (and hypertension) in patients with 
DM was investigated in a prospective study with women with DM type 1 (n=296) and type 2 
(n=348). All patients were interviewed and their medical records were reviewed at baseline 
and at study closure to collect all relevant information. All patients were asked to provide 1 or 
2 midstream urine specimens. The women were followed up for a mean (SD) duration of 6.1 
(1.9) years. Women with DM type 1 were younger, but had a longer duration of DM, than 
women with DM type 2. At baseline, 201 women with DM type 2 (58%) were treated with 
insulin only, 97 (28%) with oral hypoglycemic medication only, 41 (12%) with a combination of 
both, and five women (2%) were on a diet only (data were incomplete for 4 women). Because 
the Cockcroft-Gault formula for the estimation of the creatinine clearance includes age, 
adjusting for age in a multivariate model is not possible. Therefore patients were stratified into 
3 age strata to assess the impact of age on the association between ASB and the (relative 
increase in the) creatinine clearance (respectively 18 to 36, 37 to 55, and 56 to 75 years old). All 
analyses were performed on the entire study population and on women with DM type 1 and 
DM type 2 separately.The prevalence of ASB was 17% in the study population, lower in  
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women with type 1 DM (12%) compared to women with type 2 DM (21%), but multivariate 
analysis revealed that this was due to the difference in age. E. coli was cultured in 74 (67%) of 
the 110 women with ASB. Other isolated microorganisms included enterococci (9%), group B 
streptococci (8%), Klebsiella pneumoniae (6%), Staphylococcus aureus (3%), Proteus mirabilis (2%), 
Enterobacter species (2%).  The prevalence of leukocyturia (5 or more leukocytes per high-
power field) was 15% in women with ASB,  suggesting that bacteria were present without 
resulting into an inflammatory response. The creatinine clearance decreased from 87 at 
baseline to 76 mL/min at study endpoint in diabetic women with ASB, and from 97 
mL/min to 88 mL/min in those without ASB (Figure 2). In the univariate analysis, ASB was 
associated with a higher relative decrease in creatinine clearance (14 ± 22% and 9 ± 23% in 
women with versus women without ASB, respectively, p = 0.03), but not with the absolute 
decrease in creatinine clearance (12 ± 19 and 9 ± 20 mL/min, respectively, p = 0.12). Using 
univariate analysis, age, the length of follow-up, the duration of DM and microalbuminuria 
were identified as possible confounding factors when studying the influence of ASB on 
renal function development. Therefore, a multivariate analysis was done, according to age 
strata, and including the length of follow-up, duration of DM, and microalbuminuria at 
baseline. In the multivariate analysis no association was found between ASB and the relative 
or the absolute decrease in creatinine clearance. Also when women with DM type 1 and 
those with DM type 2 were analyzed separately, no association was found (data not shown). 
Finally, also no association with a faster decline in renal function was found when only the 
urines with E. coli as the cultured microorganism were included in the analysis  
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Fig. 2. Differences in creatinine clearance between women WITH DM with and without ASB. 
(Meiland R, Geerlings SE, Stolk RP, Netten PM, Schneeberger PM, Hoepelman AIM. 
Asymptomatic bacteriuria in women with diabetes mellitus. Arch Intern Med 2006; 166: 
2222-7.) 
Diabetic women with ASB developed hypertension more often than women without ASB 
(54% vs 37%; p=.045). However, in the multivariate analysis, including age, duration of DM, 
and length of follow-up, the association between ASB and hypertension disappeared 
(p>.20); a higher age was the strongest predictor for hypertension. In conclusion, in this 
prospective study after 6 years of follow-up, no association was found between ASB and a 
decline in renal function or the development of hypertension in women with type 1 DM or 
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type 2 DM. As shown, women with ASB at baseline had a lower creatinine clearance at 
study end point, a faster relative decrease in creatinine clearance, and hypertension more 
often when compared univariately with women without ASB. However, the differences 
were mainly explained by differences in age and duration of DM, and all differences 
disappeared in the multivariate analyses.  
Comparable results were found in a small Polish study (25 patients with DM, including both 
men and women), in which no differences in the incidence of hypertension and renal function 
decline were demonstrated between patients with and those without ASB after 14 years.  
In a recent Canadian study it was investigated whether successive isolates of urinary E. coli 
from the same diabetic woman were genetically similar. It was shown that untreated 
diabetic women with ASB may carry a genetically unique E. coli strain for up to 13 months. 
Women who received treatment for ASB had bacteriuria for a shorter duration and carried a 
single strain of E. coli for a shorter period compared with women who did not receive 
treatment. However, treatment was followed by recurrent infections for most women, 
usually with a new strain of E. coli. The ASB-causing E. coli from diabetic women did not 
have virulence characteristics typical of UTI-causing strains. This non-virulent 
microorganism might be an explanation of the low number of patients who have also 
leukocyturia, as a result of the absence of a host response to this.  
Because in the above mentioned prospective study no evidence was found that ASB in itself 
can lead to a decline in renal function, either in women with type 1 DM or in women with 
type 2 DM, it is not likely that treatment of ASB will lead to a decrease in the incidence of 
diabetic nephropathy. This is in accordance with a recent study of women with DM with 
ASB in which a comparison was made between women who received antibiotic therapy and 
women who received placebo. In that study, no difference was seen in serum creatinine 
levels after a mean follow-up of 2 years.  
In conclusion, the hypothesis that ASB will lead to renal function deterioration in women with 
DM can be rejected because no difference in renal function development, in either women with 
type 1 DM or those with type 2 DM were found. Also, the incidence of hypertension was not 
increased when comparing women with ASB versus women without ASB. Therefore, at this 
time, screening and subsequent treatment for ASB are not indicated in patients with DM. 
5. ASB in renal transplant recipients 
It has been found that up to 50% of renal transplant recipients have ASB and UTIs. Many risk 
factors contribute to the high incidence of UTIs and ASB, which can undermine graft function 
and survival. In a retrospective study the impact of ASB on renal transplant outcome was 
analysed in 189 renal transplant recipients. Screening resulted into 298 episodes of ASB in 96 
recipients (follow-up 36 months). Significant risk factors included female gender, 
glomerulonephritis as the disease that led to transplantation, and double renal transplant. 
There were no differences in serum creatinine, creatinine clearance, or proteinuria between 
patients with and without bacteriuria. The incidence of pyelonephritis in these patients was 7.6 
episodes per 100 patient-years compared with 1.1 in those without ASB. A total of 2-5 ASB 
episodes were independent factors associated with pyelonephritis whereas more than 5 
episodes was a factor associated with rejection. Studies show contradictory results whether 
antibiotic treatment results into a lower prevalence of ASB in these patients. 
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6. Conclusions 
E. coli bacteriuria is not associated with a decline in renal function or the development of 
end-stage renal failure in a population of generally healthy adult women. However, E. coli 
bacteriuria may increase the risk of future hypertension, but the pathogenesis is not 
understood. 
Women with DM (type 1 or type 2) with ASB do not have an increased risk for a faster 
decline in renal function or the development of hypertension. Therefore, screening and 
treatment of ASB in diabetic women is not warranted.  
Since nearly all studies are performed in women, it is not possible to make conclusions 
about the association between ASB, renal function and hypertension in men. 
No differences in renal function prognosis between patients with and without ASB 
following kidney transplantation were demonstrated. However, the incidence of 
pyelonephritis was much higher in the group of patients with ASB. Therefore, screening 
protocols may be beneficial in this group of patients. 
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